Orange Book product · Generic (ANDA)
LEUCOVORIN CALCIUM
LEUCOVORIN CALCIUM
At a glance
Jul 30, 2020
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 30, 2020
6 yr ago
Today
Pharmaceutical detail
Active ingredient
LEUCOVORIN CALCIUM
Strength
EQ 5MG BASE
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 211132
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LEUCOVORIN CALCIUM
- 2026VYKOURABrand (NDA)
NDA 220406 · AVYXA HOLDINGS
- 1987LEUCOVORIN CALCIUMBrand (NDA)
NDA 008107 · HOSPIRA
- 2025LEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 218200 · GLAND
- 2023LEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 216590 · MEITHEAL
- 2023LEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 217021 · HAINAN POLY
- 2020LEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 213929 · LEADING
- 2018LEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 210917 · INGENUS PHARMS LLC
- 2018LEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 207226 · FRESENIUS KABI USA
- 2018LEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 207241 · FRESENIUS KABI USA
- 2017LEUCOVORIN CALCIUM PRESERVATIVE FREEGeneric (ANDA)
ANDA 209110 · SAGENT PHARMS INC
- 2017LEUCOVORIN CALCIUM PRESERVATIVE FREEGeneric (ANDA)
ANDA 203800 · MYLAN LABS LTD
- 2012LEUCOVORIN CALCIUM PRESERVATIVE FREEGeneric (ANDA)
ANDA 200753 · SAGENT PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
